NCNMGF
ORIC icon

Nano-Cap New Millennium Growth Fund’s Oric Pharmaceuticals ORIC Stock Holding History

Nano-Cap New Millennium Growth Fund’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$271K Buy
25,000
+17,500
+233% +$159K 0.21% 100
2026
Q1 		$95K Sell
7,500
-7,500
-50% -$85.1K 0.09% 133
2025
Q4 		$123K Buy
+15,000
New +$173K 0.1% 140

Other funds holding ORIC

NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Nano-Cap New Millennium Growth Fund's ORIC Position: Q2 2026 in Review

Nano-Cap New Millennium Growth Fund increased its Oric Pharmaceuticals (ORIC) stake by 233% in Q2 2026, buying an estimated $159K and bringing the position to 25,000 shares worth $271K. The position accounts for 0.21% of the portfolio, ranked #100.

Nano-Cap New Millennium Growth Fund first reported a position in ORIC in Q4 2025 and has held it in 3 quarters since. 180 funds tracked by Wall St. Rank hold ORIC as of Q2 2026.

  • Nano-Cap New Millennium Growth Fund held 25,000 shares of Oric Pharmaceuticals worth $271K as of Q2 2026.
  • Nano-Cap New Millennium Growth Fund bought 17,500 Oric Pharmaceuticals shares in Q2 2026, an estimated $159K.
  • Oric Pharmaceuticals made up 0.21% of Nano-Cap New Millennium Growth Fund's portfolio in Q2 2026, its #100 holding.
  • Nano-Cap New Millennium Growth Fund first reported a position in Oric Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • 180 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q2 2026.

Based on Nano-Cap New Millennium Growth Fund's 13F filing for Q2 2026, filed 14 Aug 2026.